Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • DonDolowy
    Member
    • Oct 2012
    • 56

    #1

    How to quantify retrotranspon expression?

    Dear all,

    I have a RNA-seq dataset (polyA-enriched, 2x50bp, 6-plexed) from mice. I have analyzed the data using both the Tuxedo pipeline, as well as the HTseq -> DESeq pipeline, where I have been mostly interested in protein-encoding genes.

    However, now we are also interesting in quantifying expression of retrotransposons (IAP elements, SINEs, LINEs etc.) to see if there is any difference between wildtype and knockout.

    This is the point where my self-tought bioinformatic skills come short. How would one go about this, since the mapped reads will not be associated with annotated genes?

    I was thinking if I could extract the coordinates of the different elements from biomart and then use bedtools to somehow summarize their expression? Or can I just run cufflinks and use UCSC Repeatmasker track as annotation file?


    Thanks a lot! Appreciate your inputs.

    Best,

    Kevin
    Last edited by DonDolowy; 07-15-2013, 01:53 PM. Reason: Suggestions
  • DonDolowy
    Member
    • Oct 2012
    • 56

    #2
    If anyone in the future has a similar analysis in mind, I ended up doing the analysis by mapping the reads to whole mm9 genome using Bowtie2. Convert the results to bed and then use bedtools intersect to intersect the results with the Repeatmasker annotation from UCSC. Sum up the counts followed by generation of counts matrix that can be used for DESeq.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Working...